AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,005 | -29.5% | 5,198 | -56.5% | 0.00% | – |
| Q2 2023 | $11,357 | +189183.3% | 11,955 | +88.1% | 0.00% | – |
| Q1 2023 | $6 | -45.5% | 6,355 | -58.0% | 0.00% | – |
| Q4 2022 | $11 | -99.8% | 15,138 | +39.5% | 0.00% | – |
| Q3 2022 | $7,000 | -30.0% | 10,849 | +4.4% | 0.00% | – |
| Q2 2022 | $10,000 | -44.4% | 10,387 | -24.0% | 0.00% | – |
| Q1 2022 | $18,000 | -82.5% | 13,662 | -49.0% | 0.00% | -100.0% |
| Q4 2021 | $103,000 | +171.1% | 26,764 | +290.4% | 0.00% | +100.0% |
| Q3 2021 | $38,000 | +40.7% | 6,855 | +124.9% | 0.00% | 0.0% |
| Q2 2021 | $27,000 | +35.0% | 3,048 | +94.9% | 0.00% | – |
| Q1 2021 | $20,000 | -23.1% | 1,564 | -16.7% | 0.00% | -100.0% |
| Q4 2020 | $26,000 | 0.0% | 1,878 | -8.8% | 0.00% | – |
| Q3 2020 | $26,000 | -74.0% | 2,059 | -64.0% | 0.00% | -100.0% |
| Q2 2020 | $100,000 | +733.3% | 5,720 | +702.2% | 0.00% | +300.0% |
| Q1 2020 | $12,000 | -80.3% | 713 | -76.3% | 0.00% | -80.0% |
| Q4 2019 | $61,000 | +117.9% | 3,009 | +52.3% | 0.01% | +150.0% |
| Q3 2019 | $28,000 | -20.0% | 1,976 | -5.8% | 0.00% | -33.3% |
| Q4 2018 | $35,000 | – | 2,097 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |